2-Agonists: consensus guidelines not followed in asthma

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.319, 2001-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 4 and tolerance to 2 -adrenoceptor agonists in asthma

By Giembycz M.A.  

Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. : 331-336

Elsevier

Access to resources Recommend Favorite

New action for -agonists in asthma

By  

Inpharma, Vol. 1, Iss. 1401, 2003-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Consensus guidelines for the management of RA

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 324, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Evaluation of combination long-acting β-2 agonists and inhaled glucocorticosteroids for treatment of asthma

By Kim Dennis   Glaum Mark   Lockey Richard  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 933-940

Informa Healthcare

Access to resources Recommend Favorite

Patients with asthma should use intermediate-acting inhaled β 2 -agonists only on an as-needed basis

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 1, 2006-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite